Crispr/cas-related methods and compositions for knocking out c5
US-2024415980-A1 · Dec 19, 2024 · US
US9795566B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9795566-B2 |
| Application number | US-201715406050-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 13, 2017 |
| Priority date | Jul 17, 2014 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a novel imidazole compound which has a high stability of the compound itself; and a novel imidazole compound which is useful as a membrane-constituting lipid of liposomes. Disclosed are a compound represented by the following General Formula (1), and a liposome containing the same compound. In the formula, Z is an imidazolyl group which may be substituted, L 1 is an alkylene group having 1 to 4 carbon atoms which may be substituted, X is an oxygen atom or a nitrogen-containing substituent, n is an integer of 2 to 4, m is an integer of 1 to 20, L 2 is a divalent linking group having 1 to 6 carbon atoms, Y is a nitrogen-containing group, R 1 and R 2 are a hydrogen group or an alkyl group having 1 to 6 carbon atoms, R 3 is a hydrogen atom or a substituent, and R 4 and R 5 are an alkyl group having 1 to 40 carbon atoms.
Opening claim text (preview).
What is claimed is: 1. A compound represented by the following General Formula (1): in Formula (1), Z is an imidazolyl group which may have a substituent, L 1 is an alkylene group having 1 to 4 carbon atoms which may have a substituent, and X is an oxygen atom or a group represented by the following Formula (2), * is a position of bonding, n is an integer of 2 to 4, m is an integer of 1 to 20, L 2 is a divalent linking group having 1 to 6 carbon atoms, and Y is a group represented by the following Formula (3), R 1 and R 2 are the same or different and are a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R 3 is a hydrogen atom or a substituent, and R 4 and R 5 are the same or different and are an alkyl group having 1 to 40 carbon atoms. 2. The compound according to claim 1 , wherein L 1 is an alkylene group represented by the following Formula (4): in the formula, * represents a position of bonding. 3. A liposome comprising the compound according to claim 1 . 4. A liposome comprising the compound according to claim 2 .
comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543}) · CPC title
Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones · CPC title
with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title
Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant · CPC title
General methods applicable to biologically active non-coding nucleic acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.